Skip to main content
Advertisement
Advertisement
ELMD
ELMD logo
Electromed, Inc.
26.66
USD
Sponsored
+0.04
+0.15%
Oct 27, 15:59 UTC -4
Closed
exchange

Pre-Market

26.59

-0.07
-0.24%

Electromed, Inc. (ELMD) Profile

Electromed, Inc. Profile

About

Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.

Info & Links

CEO

James L. Cunniff

Headquarters

500 SIXTH AVENUE NW
NEW PRAGUE, MN 56071, UNITED STATES

Sector

Medical

Auditor

RSM US LLP

Share holders

37

Employees

197

Electromed, Inc. Statistics

Valuation Measures

Market Capitalization2

220.40M

Enterprise Value

199.95M

Enterprise Value/EBITDA(ttm)

13.37

Price to Earnings Ratio(ttm)

20.13

Price to Sales(ttm)

2.96

Price to Book(mrq)

4.05

Price to Cash(ytd)

17.64

Profitability

Gross Margin(ttm)

78.53%

Operating Margin(ttm)

15.32%

Profit Margin(ttm)

15.24%

Return on Equity(ttm)

23.38%

Return on Invested Capital(ttm)

23.26%

Return on Assets(ttm)

19.30%

Income Statement

Revenue(ttm)

73.78M

Revenue Per Share(ttm)

8.82

Gross Profit(ttm)

57.94M

EBITDA(ttm)3

14.96M

Net Income Available to Common(ttm)

11.30M

Diluted EPS(ttm)

1.31

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

8.86%

S&P 500 52-Week Change

19.75%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

8.37M

Dividend Yield

0.00%

Float4

7.38M

% Held by Insiders

11.00%

% Held by Institutions

40.82%

Balance Sheet

Total Cash(mrq)

20.45M

Total Cash Per Share(mrq)

2.44

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.69%

Quick Ratio(mrq)

4.39%

Book Value Per Share(mrq)

6.45

Cash Flow

Operating Cash Flow Per Share(ytd)

1.11

Free Cash Flow(ytd)

8.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement